TAZEMETOSTAT, IMFINZI 50 mg/mL concentrate for solution for infusion. clinical trials

CAIRE : COMBINING EPIGENETIC AND IMMUNE THERAPY TO BEAT CANCER

This study looks at combining two medicines, Tazemetostat and Imfinzi, to treat certain advanced cancers. Researchers want to see if this combination can stop cancer from growing or shrink it in patients with advanced pancreatic, bowel, or soft tissue cancers, and other specific advanced solid tumours.